Cardiff Oncology, Inc. (CRDF)
3.08
-0.09
(-2.84%)
USD |
NASDAQ |
Jan 09, 16:00
3.07
-0.01
(-0.32%)
After-Hours: 20:00
Cardiff Oncology Research and Development Expense (Annual): 36.85M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Agenus, Inc. | 155.53M |
| AIM ImmunoTech, Inc. | 6.149M |
| Perspective Therapeutics, Inc. | 39.33M |
| Protalix Biotherapeutics, Inc. | 12.97M |
| Armata Pharmaceuticals, Inc. | 34.43M |